selected scholarly activity
-
academic article
- The Contributions of Prostate Cancer Stem Cells in Prostate Cancer Initiation and Metastasis. Cancers. 11:434-434. 2019
- A Phase II, Randomized, Multicenter Study Comparing 10 Months versus 4 Months of Degarelix Therapy in Prolonging the Off Treatment Interval in Men with Localized Prostate Cancer Receiving Intermittent Androgen Deprivation Therapy for Biochemical Recurrence following Radical Local Therapy. JOURNAL OF UROLOGY. 200:335-343. 2018
- Adjuvant Therapies in Nonmetastatic Renal-Cell Carcinoma: A Review of the Literature. Clinical Genitourinary Cancer. 16:176-183. 2018
- The true malignancy risk of Bosniak III cystic renal lesions: Active surveillance or surgical resection?. Journal of the Canadian Urological Association. 12:E276-E280. 2018
- The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT2-3 non-metastatic renal cell carcinoma treated with radical nephrectomy. BJU International. 121:383-392. 2018
- Comparison of Partial Versus Radical Nephrectomy Effect on Other-cause Mortality, Cancer-specific Mortality, and 30-day Mortality in Patients Older Than 75 Years. European Urology Focus. 2018
- Prostate cancer screening among family physicians in Ontario: An update on attitudes and current practice. Journal of the Canadian Urological Association. 12:E53-E58. 2018
- Effect of pathological high-risk features on cancer-specific mortality in non-metastatic clear cell renal cell carcinoma: a tool for optimizing patient selection for adjuvant therapy. World Journal of Urology. 36:51-57. 2018
- Autoantibodies against the cell surface–associated chaperone GRP78 stimulate tumor growth via tissue factor. Journal of Biological Chemistry. 292:21180-21192. 2017
- Follow-up imaging after nephrectomy for cancer in Canada: urologists' compliance with guidelines. An observational study. CMAJ Open. 5:E834-E841. 2017
- Marital status and gender affect stage, tumor grade, treatment type and cancer specific mortality in T1–2 N0 M0 renal cell carcinoma. World Journal of Urology. 35:1899-1905. 2017
- Survival after Cytoreductive Nephrectomy in Metastatic Non-clear Cell Renal Cell Carcinoma Patients: A Population-based Study. European Urology Focus. 2017
- Survival of metastatic renal cell carcinoma patients continues to improve over time, even in targeted therapy era. International Urology and Nephrology. 49:2143-2149. 2017
- Overexpression of MUC1 and Genomic Alterations in Its Network Associate with Prostate Cancer Progression. Neoplasia. 19:857-867. 2017
- Management of advanced kidney cancer: Canadian Kidney Cancer Forum (CKCF) consensus update 2017. Journal of the Canadian Urological Association. 11:310-310. 2017
- Corrigendum to “Nuclear transportation of exogenous epidermal growth factor receptor and androgen receptor via extracellular vesicles” [Eur J Cancer 70 (2017) 62–74]. European Journal of Cancer. 83:335-335. 2017
- Current management of metastatic renal cell carcinoma. Current Opinion in Supportive and Palliative Care. 11:231-237. 2017
- Benchmarking quality for renal cancer surgery: Canadian Kidney Cancer information system (CKCis) perspective. Journal of the Canadian Urological Association. 11:232-232. 2017
- Highlights of genitourinary cancer research presented at ASCO 2017. Journal of the Canadian Urological Association. 11:297-297. 2017
- A Multicentered, Propensity Matched Analysis Comparing Laparoscopic and Open Surgery for pT3a Renal Cell Carcinoma. Journal of Endourology. 31:645-650. 2017
- Adjuvant Weekly Girentuximab Following Nephrectomy for High-Risk Renal Cell Carcinoma. JAMA Oncology. 3:913-913. 2017
- Positive surgical margins during partial nephrectomy for renal cell carcinoma: Results from Canadian Kidney Cancer information system (CKCis) collaborative. Journal of the Canadian Urological Association. 11:182-182. 2017
- Update from the American Society of Clinical Oncology 2017 Genitourinary Cancers Symposium (ASCO-GU). Journal of the Canadian Urological Association. 11:159-159. 2017
- Epidemiology of prostate and kidney cancer in the Aboriginal population of Canada: A systematic review. Journal of the Canadian Urological Association. 11:222-222. 2017
- Safety, reliability and accuracy of small renal tumour biopsies: results from a multi-institution registry. BJU International. 119:543-549. 2017
- Upregulation of FAM84B during prostate cancer progression. Oncotarget. 8:19218-19235. 2017
- Erratum to “The natural history of renal function after surgical management of renal cell carcinoma: Results from the Canadian Kidney Cancer Information System” [Urol Oncol 34(11) (2016) 486.e1–486.e7]. Urologic Oncology: Seminars and Original Investigations Seminars in Urologic Oncology. 35:124-124. 2017
- First-line sunitinib or pazopanib in metastatic renal cell carcinoma: The Canadian experience. Journal of the Canadian Urological Association. 11:112-112. 2017
- Systematic review of the potential role of cannabinoids as antiproliferative agents for urological cancers. Journal of the Canadian Urological Association. 11:138-138. 2017
- Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma. World Journal of Urology. 35:355-365. 2017
- Re: Kapoor et al.: Evolving Strategies in the Treatment of Tuberous Sclerosis Complex-associated Angiomyolipomas (TSC-AML) (Urology 2016; 89:19-26) Reply. Urology. 100:255-255. 2017
- Reply by the Authors. Urology. 100:255-255. 2017
- Enzyme replacement therapy for Anderson-Fabry disease: A complementary overview of a Cochrane publication through a linear regression and a pooled analysis of proportions from cohort studies. PLoS ONE. 12:e0173358-e0173358. 2017
- Next generation quality: Assessing the physician in clinical history completeness and diagnostic interpretations using funnel plots and normalized deviations plots in 3,854 prostate biopsies. Journal of Pathology Informatics. 8:43-43. 2017
- Nuclear transportation of exogenous epidermal growth factor receptor and androgen receptor via extracellular vesicles. European Journal of Cancer. 70:62-74. 2017
- Amplification of MUC1 in prostate cancer metastasis and CRPC development. Oncotarget. 7:83115-83133. 2016
- Electrical stimulation with non-implanted electrodes for overactive bladder in adults. Cohrane Library Clinical Respiratory Journal. 12:CD010098. 2016
- Sunitinib: 10 years of clinical experience in the treatment of advanced renal cell carcinoma. Journal of the Canadian Urological Association. 10:235-235. 2016
- Update on Bladder, Kidney, and Prostate Cancer from the European Society for Medical Oncology (ESMO) Annual Meeting 2016. Journal of the Canadian Urological Association. 10:223-223. 2016
- Contemporary agents in the management of metastatic castration-resistant prostate cancer. Journal of the Canadian Urological Association. 10:414-414. 2016
- Disease progression and kidney function after partial vs. radical nephrectomy for T1 renal cancer. Urologic Oncology: Seminars and Original Investigations Seminars in Urologic Oncology. 34:486.e17-486.e23. 2016
- First-line treatment options in metastatic renal cell cancer. Journal of the Canadian Urological Association. 10:236-236. 2016
- Kidney cancer, ESMO 2016. Journal of the Canadian Urological Association. 10:227-227. 2016
- The natural history of renal function after surgical management of renal cell carcinoma: Results from the Canadian Kidney Cancer Information System. Urologic Oncology: Seminars and Original Investigations Seminars in Urologic Oncology. 34:486.e1-486.e7. 2016
- Evidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasia. Therapeutic Advances in Urology. 8:257-271. 2016
- Pathological Upstaging of Clinical T1 to Pathological T3a Renal Cell Carcinoma: A Multi-institutional Analysis of Short-term Outcomes. Urology. 94:154-160. 2016
- Prostate cancer update from the American Society of Clinical Oncology (ASCO) annual meeting 2016. Canadian Urological Association Journal. 10:137-137. 2016
- Impact of resident involvement in endoscopic bladder cancer surgery on pathological outcomes. Scandinavian Journal of Urology. 50:234-238. 2016
- Update from the European Association of Urology (EAU) Annual Meeting 2016. Canadian Urological Association Journal. 10:123-123. 2016
- What’s new in prostate cancer research?. Canadian Urological Association Journal. 10:127-127. 2016
- What’s new in testosterone deficiency research?. Canadian Urological Association Journal. 10:130-130. 2016
- What’s new renal cancer research?. Canadian Urological Association Journal. 10:132-132. 2016
- Electrical stimulation with non-implanted electrodes for overactive bladder in adults. Cochrane Database of Systematic Reviews. 4:CD010098. 2016
- CYB5D2 displays tumor suppression activities towards cervical cancer. Biochimica et Biophysica Acta - Molecular Basis of Disease. 1862:556-565. 2016
- Neural Cell Adhesion Protein CNTN1 Promotes the Metastatic Progression of Prostate Cancer. Cancer Research. 76:1603-1614. 2016
- Dataset on the effects of CYB5D2 on the distribution of HeLa cervical cancer cell cycle. Data in Brief. 6:811-816. 2016
- Evolving Strategies in the Treatment of Tuberous Sclerosis Complex-associated Angiomyolipomas (TSC-AML). Urology. 89:19-26. 2016
- Intrinsic ureteral endometriosis as a cause of unilateral obstructive uropathy. Journal of the Canadian Urological Association. 10:119-119. 2016
- Aromatase inhibitors in the treatment of oligozoospermic or azoospermic men: a systematic review of randomized controlled trials. Jornal Brasileiro de Reproducao Assistida. 20:82-88. 2016
- Emphysematous pyelonephritis in failed renal allograft:Case report and review of literature. Urology Annals. 8:111-111. 2016
- Contrast-enhanced Ultrasonography for Surveillance of Radiofrequency-ablated Renal Tumors: A Prospective, Radiologist-blinded Pilot Study. Urology. 86:1174-1178. 2015
- Clinical outcomes following laparoscopic management of pT3 renal masses: A large, multi-institutional cohort. Canadian Urological Association Journal. 9:397-397. 2015
- Differences between the real and the desired worlds in the results of clinical trials. Clinics. 70:618-622. 2015
- A Prospective Randomized Study of Pfannenstiel Versus Expanded Port Site Incision for Intact Specimen Extraction in Laparoscopic Radical Nephrectomy. Journal of Endourology. 29:913-918. 2015
- Oncology Brief from ASCO 2015: Update on Kidney Cancer and Prostate Cancer. Journal of the Canadian Urological Association. 9:157-157. 2015
- The role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma following radical nephroureterectomy: a retrospective study. BJU International. 116:72-78. 2015
- Current Concepts in Genitourinary Oncology: GU-ASCO 2015. Journal of the Canadian Urological Association. 9:147-147. 2015
- Angiosarcoma of the adrenal gland with concurrent contralateral advanced renal cell carcinoma: A diagnostic and management dilemma. Journal of the Canadian Urological Association. 9:302-302. 2015
- Canadian guidelines for the management of the small renal mass (SRM). Journal of the Canadian Urological Association. 9:160-160. 2015
- Management of advanced kidney cancer: Canadian Kidney Cancer Forum consensus update. Journal of the Canadian Urological Association. 9:164-164. 2015
- Renal cell carcinoma and amyopathic dermatomyositis. Journal of the Canadian Urological Association. 9:340-340. 2015
- What’s New in Prostate Cancer Research? Highlights of GU-ASCO 2015. Journal of the Canadian Urological Association. 9:148-148. 2015
- What’s New in Renal Cell Cancer Research? Highlights of GU-ASCO 2015. Journal of the Canadian Urological Association. 9:154-154. 2015
- Conditional Survival After Radical Nephroureterectomy for Upper Tract Carcinoma. European Urology. 67:803-812. 2015
- Surgical Management of Stage T1 Renal Tumors in Canadian Academic Centers. Journal of the Canadian Urological Association. 9:99-99. 2015
- The 2014 CUA-CUOG Guidelines for the Management of Castration Resistant Prostate Cancer (CRPC). Journal of the Canadian Urological Association. 9:90-90. 2015
- Prostate cancer stem cells: deciphering the origins and pathways involved in prostate tumorigenesis and aggression. Oncotarget. 6:1900-1919. 2015
- Plasma exchange to remove HIT antibodies: dissociation between enzyme-immunoassay and platelet activation test reactivities. Blood. 125:195-198. 2015
- Renal tumour scoring systems: How useful are they?. Journal of the Canadian Urological Association. 9:46-46. 2015
- Mesure de l’APS : Et maintenant… un message de nos experts. Journal of the Canadian Urological Association. 8:944-944. 2014
- PSA screening: And now…a message from our experts. Journal of the Canadian Urological Association. 8:387-387. 2014
- The impact of method of distal ureter management during radical nephroureterectomy on tumour recurrence. Journal of the Canadian Urological Association. 8:845-845. 2014
- Update on medical expulsive therapy for distal ureteral stones: Beyond alpha-blockers. Journal of the Canadian Urological Association. 8:442-442. 2014
- Common reduction of the Raf kinase inhibitory protein in clear cell renal cell carcinoma. Oncotarget. 5:7406-7419. 2014
- Laparoscopic nephrectomy for massive polycystic kidney disease: Updated technique and outcomes. Journal of the Canadian Urological Association. 8:341-341. 2014
- Risk factors for bladder cancer recurrence after nephroureterectomy for upper tract urothelial tumors: Results from the Canadian Upper Tract Collaboration1Co-first authors.. Urologic Oncology: Seminars and Original Investigations Seminars in Urologic Oncology. 32:839-845. 2014
- Metastatic renal cell carcinoma without evidence of a primary renal tumour. Current Oncology. 21:521-521. 2014
- Effect of body mass index on the outcomes of patients with upper and lower urinary tract cancers treated by radical surgery: Results from a Canadian multicenter collaboration. Urologic Oncology: Seminars and Original Investigations Seminars in Urologic Oncology. 32:441-448. 2014
- Surgical management of renal cell carcinoma: Canadian Kidney Cancer Forum Consensus. Journal of the Canadian Urological Association. 8:398-398. 2014
- The robotic invasion in Canada. Journal of the Canadian Urological Association. 8:151-151. 2014
- Laparoscopic Management of Advanced Renal Cell Carcinoma With Renal Vein and Inferior Vena Cava Thrombus. Urology. 83:812-817. 2014
- Update on Cryoablation for Treatment of Small Renal Mass: Oncologic Control, Renal Function Preservation, and Rate of Complications. Current Urology Reports. 15:396. 2014
- « Je vous l’avais bien dit » : Examen de l’incidence de la liste de contrôle de la sécurité chirurgicale. Journal of the Canadian Urological Association. 8:221-221. 2014
- Canadian content at GU-ASCO 2014: Highlights of research involving Canadian researchers. Canadian Urological Association Journal. 8:16-16. 2014
- New paradigms in the treatment of genitourinary malignancies: GU-ASCO Update 2014. Canadian Urological Association Journal. 8:7-7. 2014
- What’s new in prostate cancer research? Highlights of GU-ASCO 2014. Canadian Urological Association Journal. 8:8-8. 2014
- What’s new in renal cell cancer research? Highlights of GU-ASCO 2014. Canadian Urological Association Journal. 8:13-13. 2014
- “I told you so”: Examining the impact of the surgical safety checklist. Journal of the Canadian Urological Association. 8:79-79. 2014
- Middle East Respiratory Syndrome Coronavirus Infection in Dromedary Camels in Saudi Arabia. mBio. 5:e00884-e00814. 2014
- Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: Assessment of adequate renal function and influence on outcome. Urologic Oncology: Seminars and Original Investigations Seminars in Urologic Oncology. 32:31.e17-31.e24. 2014
- An alternative approach to deal with the absence of clinical trials: a proportional meta-analysis of case series studies. Acta Cirurgica Brasileira. 28:870-876. 2013
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation. New England Journal of Medicine. 369:2093-2104. 2013
- Clear cell renal cell carcinoma induces fibroblast-mediated production of stromal periostin. European Journal of Cancer. 49:3537-3546. 2013
- Comparison of oncological outcomes for open and laparoscopic radical nephroureterectomy: results from the Canadian Upper Tract Collaboration. BJU International. 112:791-797. 2013
- Multifocality rather than tumor location is a prognostic factor in upper tract urothelial carcinoma. Urologic Oncology: Seminars and Original Investigations Seminars in Urologic Oncology. 31:1161-1165. 2013
- Canadian guideline on genetic screening for hereditary renal cell cancers. Journal of the Canadian Urological Association. 7:319-319. 2013
- Canadian guidelines for postoperative surveillance of upper urinary tract urothelial carcinoma. Journal of the Canadian Urological Association. 7:306-306. 2013
- Comorbidity Status Does Not Independently Predict Survival Outcomes After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma. European Urology. 64:518-519. 2013
- Using the Delphi Technique to Improve Clinical Outcomes Through the Development of Quality Indicators in Renal Cell Carcinoma. Journal of Oncology Practice. 9:e262-e267. 2013
- CUA-CUOG Guidelines for the Management of Castration Resistant Prostate Cancer (CRPC): 2013 Update. Journal of the Canadian Urological Association. 7:231-231. 2013
- Dutasteride for the treatment of benign prostatic hyperplasia. Expert Opinion on Pharmacotherapy. 14:1399-1408. 2013
- Management of renal collecting duct carcinoma: a systematic review and the McMaster experience. Current Oncology. 20:223-223. 2013
- Cost-utility analysis of radical nephrectomy versus partial nephrectomy in the management of small renal masses: adjusting for the burden of ensuing chronic kidney disease. Journal of the Canadian Urological Association. 7:108-108. 2013
- The method of bladder cuff excision during laparoscopic radical nephroureterectomy does not affect oncologic outcomes in upper tract urothelial carcinoma. World Journal of Urology. 31:175-181. 2013
- Regulation of the Tumor Suppressor PTEN through Exosomes: A Diagnostic Potential for Prostate Cancer. PLoS ONE. 8:e70047-e70047. 2013
- Review of the efficacy and safety of cryoablation for the treatment of small renal masses.. Journal of the Canadian Urological Association. 7:E38-E44. 2013
- Regional differences in practice patterns and associated outcomes for upper tract urothelial carcinoma in Canada.. Journal of the Canadian Urological Association. 6:455-462. 2012
- Benign prostatic hyperplasia (BPH) management in the primary care setting.. Canadian Journal of Urology. 19 Suppl 1:10-17. 2012
- Laparoscopic partial nephrectomy: The McMaster University experience. Journal of the Canadian Urological Association. 6:233-237. 2012
- Cryoablation vs radiofrequency ablation for the treatment of renal cell carcinoma: a meta-analysis of case series studies. BJU International. 110:510-516. 2012
- Prostate cancer screening: Attitudes and practices of family physicians in Ontario. Journal of the Canadian Urological Association. 6:188-193. 2012
- IQGAP2, A candidate tumour suppressor of prostate tumorigenesis. Biochimica et Biophysica Acta - Molecular Basis of Disease. 1822:875-884. 2012
- Transfer of Laparoscopic Radical Prostatectomy Skills From Bench Model to Animal Model: A Prospective, Single-Blind, Randomized, Controlled Study. JOURNAL OF UROLOGY. 187:1861-1866. 2012
- The Contemporary Role of Lymph Node Dissection During Nephroureterectomy in the Management of Upper Urinary Tract Urothelial Carcinoma: The Canadian Experience. Urology. 79:840-845. 2012
- Adenovirus-Mediated Gene Transfer of TGF-β1 to the Renal Glomeruli Leads to Proteinuria. American Journal of Pathology. 180:940-951. 2012
- Commercial renal transplantation: A risky venture? A single Canadian centre experience. Journal of the Canadian Urological Association. 5:335-340. 2011
- Guidelines for the diagnosis and management of recurrent urinary tract infection in women. Journal of the Canadian Urological Association. 5:316-322. 2011
- Progression-free survival as a clinical trial endpoint in advanced renal cell carcinoma.. Current Oncology. 18 Suppl 2:S11-S19. 2011
- Current systemic management of metastatic renal cell carcinoma – first line and second line therapy. Current Opinion in Supportive and Palliative Care. 5:211-221. 2011
- α-Mannosidase 2C1 attenuates PTEN function in prostate cancer cells. Nature Communications. 2:307. 2011
- Guidelines for the management of the incidentally discovered adrenal mass. Journal of the Canadian Urological Association. 5:241-247. 2011
- A System for Laparoscopic Surgery Ergonomics and Skills Evaluation. Journal of Endourology. 25:1111-1114. 2011
- Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells. Biochimica et Biophysica Acta - Molecular Cell Research. 1813:683-694. 2011
- Emerging novel therapies in the treatment of castrate-resistant prostate cancer. Journal of the Canadian Urological Association. 5:120-133. 2011
- Laparoscopic pyeloplasty: the standard of care for ureteropelvic junction obstruction. Journal of the Canadian Urological Association. 5:136-138. 2011
- Life before and after residents: subjective reports on quality of life from urologists since inception of a new residency program. Journal of the Canadian Urological Association. 5:103-106. 2011
- Renal histopathology features according to various warm ischemia times in porcine laparoscopic and open surgery model. Journal of the Canadian Urological Association. 5:40-43. 2011
- Outcomes of laparoscopic donor nephrectomy in the presence of multiple renal arteries. Urology Annals. 3:62-62. 2011
- Binding of Anti-GRP78 Autoantibodies to Cell Surface GRP78 Increases Tissue Factor Procoagulant Activity via the Release of Calcium from Endoplasmic Reticulum Stores. Journal of Biological Chemistry. 285:28912-28923. 2010
- Preferred management option for small renal masses: laparoscopic partial nephrectomy. Journal of the Canadian Urological Association. 4:139-141. 2010
- Safety and clinical efficacy of everolimus in the treatment of advanced renal cell carcinoma (RCC).. Drug, Healthcare and Patient Safety. 2:85-91. 2010
- Cytoreductive nephrectomy in metastatic renal cell carcinoma: the evolving role of surgery in the era of molecular targeted therapy. Current Opinion in Supportive and Palliative Care. 3:157-165. 2009
- Targeted inhibition of mammalian target of rapamycin for the treatment of advanced renal cell carcinoma. Cancer. 115:3618-3630. 2009
- Obesity and renal cell carcinoma: epidemiology, underlying mechanisms and management considerations. Expert Review of Anticancer Therapy. 9:975-987. 2009
- Laparoscopic partial nephrectomy: a challenging operation with a steep learning curve. Journal of the Canadian Urological Association. 3:119-119. 2009
- Laparoscopic right donor nephrectomy. BJU International. 103:998-1013. 2009
- Outcome of Third Renal Allograft Retransplants Versus Primary Transplants from Paired Donors. Transplantation. 87:1214-1220. 2009
- Review of the efficacy and safety of radiofrequency ablation for the treatment of small renal masses. Journal of the Canadian Urological Association. 3:143-143. 2009
- Task-specific bench model training versus basic laparoscopic skills training for laparoscopic radical prostatectomy: a randomized controlled study. Journal of the Canadian Urological Association. 3:22-22. 2009
- Adjuvant and neoadjuvant small-molecule targeted therapy in high-risk renal cell carcinoma. Current Oncology. 16:S62-S68. 2009
- Inhibition of mTOR in kidney cancer. Current Oncology. 16:S35-S41. 2009
- PTEN inhibits BMI1 function independently of its phosphatase activity. Molecular Cancer. 8:98-98. 2009
- Specific Reduction of Fas-Associated Protein with Death Domain (FADD) in Clear Cell Renal Cell Carcinoma. Cancer Investigation. 27:836-843. 2009
- Treatment of adult rhabdoid renal cell carcinoma with sorafenib. Journal of the Canadian Urological Association. 2:631-631. 2008
- Bmi1 promotes prostate tumorigenesis via inhibiting p16INK4A and p14ARF expression. Biochimica et Biophysica Acta - Molecular Basis of Disease. 1782:642-648. 2008
- Lower Plasma Adiponectin Levels Are Associated with Larger Tumor Size and Metastasis in Clear-Cell Carcinoma of the Kidney. European Urology. 54:866-874. 2008
- Laparoscopic pyeloplasty: the updated McMaster University experience. Journal of the Canadian Urological Association. 2:388-388. 2008
- Laparoscopic Nephrectomy with Intact Specimen Extraction for Polycystic Kidney Disease. Journal of Endourology. 22:675-680. 2008
- Laparoscopic pyeloplasty: Role of preoperative retrograde pyelography. Journal of Pediatric Urology. 4:162-164. 2008
- Malignancy in Kidney Transplant Recipients. Drugs. 68:11-19. 2008
- Co-existence of high levels of the PTEN protein with enhanced Akt activation in renal cell carcinoma. Biochimica et Biophysica Acta - Molecular Basis of Disease. 1772:1134-1142. 2007
- Uncertainty in ultrasound reporting. Journal of the Canadian Urological Association. 1:255. 2007
- Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma. New England Journal of Medicine. 356:2271-2281. 2007
- Intact Specimen Extraction in Laparoscopic Nephrectomy Procedures: Pfannenstiel Versus Expanded Port Site Incisions. Urology. 69:241-244. 2007
- Comparison of laparoscopic and open nephrectomy for adult polycystic kidney disease: operative challenges and technique.. Canadian Journal of Urology. 13:3340-3345. 2006
- ATM activation is accompanied with earlier stages of prostate tumorigenesis. Biochimica et Biophysica Acta - Molecular Cell Research. 1763:1090-1097. 2006
- Laparoscopic excision of para-aortic ectopic pheochromocytoma.. Canadian Journal of Urology. 13:3271-3274. 2006
- Laparoscopic management of advanced renal cell carcinoma with level I renal vein thrombus. Urology. 68:514-517. 2006
- Robot-assisted laparoscopic renal artery aneurysm reconstruction. Journal of Vascular Surgery. 44:651-653. 2006
- Radiation-induced genomic instability is associated with DNA methylation changes in cultured human keratinocytes. MUTATION RESEARCH. 597:87-97. 2006
- ERK activity facilitates activation of the S-phase DNA damage checkpoint by modulating ATR function. Oncogene. 25:1153-1164. 2006
- TERMINAL LOOP CUTANEOUS URETEROSTOMY IN RENAL TRANSPLANTATION: AN UNDER UTILIZED URINARY DIVERSION TECHNIQUE. JOURNAL OF UROLOGY. 174:1906-1909. 2005
- Urological manifestations of BK polyomavirus in renal transplant recipients.. Canadian Journal of Urology. 12:2829-2836. 2005
- Laparoscopic nephrectomy for emphysematous pyelonephritis.. Canadian Journal of Urology. 12:2764-2768. 2005
- Identification of a novel Wee1 isoform. Biochimica et Biophysica Acta - Gene Structure and Expression Biochimica et Biophysica Acta - Gene Regulatory Mechanisms. 1729:1-9. 2005
- Primary small cell carcinoma of the ureter.. Canadian Journal of Urology. 12:2603-2606. 2005
- ATM activity contributes to the tumor-suppressing functions of p14ARF. Oncogene. 23:7355-7365. 2004
- Comparison of Laparoscopic Radical Renal Surgery in Morbidly Obese and Non-obese Patients. Journal of Endourology. 18:657-660. 2004
- Laparoscopic versus open partial nephrectomy. Urology. 64:458-461. 2004
- McMaster experience with laparoscopic pyeloplasty.. Canadian Journal of Urology. 11:2299-2302. 2004
- Technique of laparoscopic nephrectomy in a patient with previous urinary diversion.. Canadian Journal of Urology. 10:2017-2019. 2003
- Herpes zoster infection: a rare cause of acute urinary retention.. Canadian Journal of Urology. 10:1912-1913. 2003
- Apoptotic Release of Histones from Nucleosomes. Journal of Biological Chemistry. 277:12001-12008. 2002
- Laparoscopic wedge resection of a renal mass in a solitary kidney.. Canadian Journal of Urology. 8:1297-1299. 2001
- ARTHROGRYPOSIS MULTIPLEX CONGENITA: BLOOD VESSEL HYPOPLASIA AND IMPLICATIONS DURING RENAL TRANSPLANTATION. JOURNAL OF UROLOGY. 165:174-174. 2001
- A Physical Modeling Study of Fluid-flow Phenomena in Gas-Slag.. ISIJ International. 37:829-838. 1997
-
conference paper
- Assessing interrater variation with funnel plots in 2,190 prostate biopsies. Virchows Archiv. S27-S27. 2017
- Phase II study of individualized sunitinib (SUN) as first-line therapy for metastatic renal cell cancer: Pharmacokinetic data. Annals of Oncology. 2017
- New research in bladder cancer, ASCO 2017. Journal of the Canadian Urological Association. 301-301. 2017
- New research in kidney cancer, ASCO 2017. Journal of the Canadian Urological Association. 298-298. 2017
- New research in prostate cancer, ASCO 2017. Journal of the Canadian Urological Association. 303-303. 2017
- Real world outcomes of patients with metastatic renal cell carcinoma (mRCC) using first-line sunitinib or pazopanib: the Canadian experience. Annals of Oncology. 2016
- Androgen receptor axis-targeted agents. Canadian Urological Association Journal. 146-146. 2016
- Chemotherapy research for metastatic prostate cancer. Canadian Urological Association Journal. 140-140. 2016
- HOW EFFECTIVE IS ELECTRICAL STIMULATION WITH NON-IMPLANTED DEVICES IN TREATING OVERACTIVE BLADDER? A COCHRANE SYSTEMATIC REVIEW AND META-ANALYSIS. Neurourology and Urodynamics. S379-S380. 2016
- Localized prostate cancer. Canadian Urological Association Journal. 138-138. 2016
- Radionulcides. Canadian Urological Association Journal. 144-144. 2016
- Phase II study of individualized sunitinib as first-line therapy for metastatic renal cell cancer (mRCC).. Journal of Clinical Oncology. 4555-4555. 2015
- The impact of renal cell carcinoma histopathological subtype on disease prognosis: A Canadian multi-institutional analysis.. Journal of Clinical Oncology. 480-480. 2015
- The proportion and characterization of patients with metastatic renal cell carcinoma who are never treated or have delayed treatment with targeted therapy: Results from a large prospective cohort.. Journal of Clinical Oncology. 424-424. 2015
- Contemporary outcomes of pT3 renal cell carcinoma: A Canadian multi-institutional experience.. Journal of Clinical Oncology. 434-434. 2014
- Positive surgical margins after partial nephrectomy for renal cell carcinoma: Results from Canadian Kidney Cancer Information System database.. Journal of Clinical Oncology. 420-420. 2014
- The role of FSH in castration-induced adipogenesis: Highlighting differences between orchiectomy, GNRH agonists, and antagonists.. Journal of Clinical Oncology. 2013
- Improving outcomes through the development of quality indicators in renal cell cancer.. Journal of Clinical Oncology. 422-422. 2012
- Risk factors for bladder cancer recurrence after nephroureterectomy for upper tract urothelial tumors: A multicenter analysis of 742 patients. European Urology, Supplements. E767-U628. 2012
- Neoadjuvant temsirolimus in high-risk renal cell carcinoma: Results from a single-center prospective study.. Journal of Clinical Oncology. 387-387. 2011
- Correlation of computerized tomography measurement of visceral adiposity with plasma adiponectin levels and presence of metastatic disease in patients with clear cell renal cell carcinoma. Journal of Clinical Oncology. 5118-5118. 2008
- Lower plasma adiponectin levels are associated with larger tumor size and metastasis in clear cell carcinoma of the kidney. Journal of Clinical Oncology. 22225-22225. 2008
- Progression free survival in patients with metastatic and recurrent renal cancer treated with sorafenib—Single center experience. Journal of Clinical Oncology. 16141-16141. 2008
- Current status of cytokine therapy in management of patients with metastatic renal cell carcinoma. Journal of the Canadian Urological Association. S28-S33. 2007
- Systemic therapy for patients with advanced, unresectable or metastatic renal cell carcinoma: moving to guidelines. Journal of the Canadian Urological Association. S34-S40. 2007
- Transforming growth factor beta 1 over expression in the rodent kidney - A non-inflammatory model of chronic allograft nephropathy.. American Journal of Transplantation. 417-417. 2007
- A phase 3, randomized, 3-arm study of temsirolimus (TEMSR) or interferon-alpha (IFN) or the combination of TEMSR plus IFN in the treatment of first-line, poor-risk patients with advanced renal cell carcinoma (adv RCC). Journal of Clinical Oncology. 930S-930S. 2006
- A phase III, randomized, 3-arm study of temsirolimus (TEMSR) or interferon-alpha (IFN) or the combination of TEMSR plus IFN in the treatment of first-line, poor-prognosis patients with advanced renal cell carcinoma.. Journal of Clinical Oncology. 2S-2S. 2006
- A phase 3, randomized, 3-arm study of temsirolimus (TEMSR) or interferon-alpha (IFN) or the combination of TEMSR plus IFN in the treatment of first-line, poor-risk patients with advanced renal cell carcinoma (ADV RCC). Annals of Oncology. 54-54. 2006